T

Trajan Group Holdings Ltd
ASX:TRJ

Watchlist Manager
Trajan Group Holdings Ltd
ASX:TRJ
Watchlist
Price: 1.095 AUD 7.35% Market Closed
Market Cap: 166.7m AUD
Have any thoughts about
Trajan Group Holdings Ltd?
Write Note

Gross Margin
Trajan Group Holdings Ltd

39.1%
Current
39%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
39.1%
=
Gross Profit
60.6m
/
Revenue
155m

Gross Margin Across Competitors

Country AU
Market Cap 166.7m AUD
Gross Margin
39%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 200.7B USD
Gross Margin
41%
Country US
Market Cap 166.2B USD
Gross Margin
60%
Country KR
Market Cap 66.7T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.6B USD
Gross Margin
55%
Country US
Market Cap 36.5B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 161.6B CNY
Gross Margin
40%
No Stocks Found

Trajan Group Holdings Ltd
Glance View

Market Cap
166.7m AUD
Industry
Life Sciences Tools & Services

Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.

TRJ Intrinsic Value
2.868 AUD
Undervaluation 62%
Intrinsic Value
Price
T

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
39.1%
=
Gross Profit
60.6m
/
Revenue
155m
What is the Gross Margin of Trajan Group Holdings Ltd?

Based on Trajan Group Holdings Ltd's most recent financial statements, the company has Gross Margin of 39.1%.